FDA Inspection
Eversight Illinois, BloomingtonEversight Illinois, Bloomington – FDA Inspection, Jan 29, 2009
Record Details
This FDA Inspection record concerns Eversight Illinois, Bloomington, with an inspection on January 29, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 29, 2009
- Product Type
- Biologics
View Company Profile
ID · 64d7d76a-b063-47f0-83b7-52a33f357e91
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 557227
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
5- 21 CFR 1271.160(b)(3)Actions verified, short and long term solutions
- 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
- 21 CFR 1271.350(b)(2)Deviations not reported to FDA
- 21 CFR 1271.180(c)Availability of procedures
- 21 CFR 1271.210(d)(1)Receipt documentation elements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eversight Illinois, Bloomington
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 14, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 27, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Eversight Illinois, Bloomington
- FDA Inspection 1062724 - 2018-07-24
- FDA Inspection 968469 - 2016-04-14
- FDA Inspection 640987 - 2010-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.